PD‐L1 and PD‐1 Expression in Thyroid Follicular Epithelial Dysplasia : Hashimoto Thyroiditis Related Atypia and Potential Papillary Carcinoma Precursor
Pakkanen, E., Kalfert, D., Ahtiainen, M., Ludvíková, M., Kuopio, T., & Kholová, I. (2022). PD‐L1 and PD‐1 Expression in Thyroid Follicular Epithelial Dysplasia : Hashimoto Thyroiditis Related Atypia and Potential Papillary Carcinoma Precursor. Apmis, 130(5), 276-283. https://doi.org/10.1111/apm.13218
Published in
ApmisAuthors
Date
2022Copyright
© 2022 the Authors
Programmed cell death ligand (PD-L1)/PD-1 expression has been studied in a variety of cancers and blockage of PD-L1/PD-1 pathway is a cornerstone of immunotherapy. We studied PD-L1/PD-1 immunohistochemical expression in 47 thyroid gland specimens in groups of 1) Hashimoto thyroiditis (HT) only, 2) HT and follicular epithelial dysplasia (FED) and 3) HT, FED and papillary thyroid carcinoma (PTC). PD-1 positivity was found in immune cells, namely in lymphocytes, macrophages, and plasma cells with mean values for lymphocytes and macrophages 9% in HT group, 4% in FED group, and 4% in PTC group. PD-L1 positivity was identified in both immune cells and in the normal epithelial cells. In the HT group, mean PD-L1 staining on immune cells was 6%, in FED group 5%, and in PTC group 7%. The mean PD-L1 staining on the epithelial cells in the inflammatory parenchyma was 11.7% in HT, 13.4% in FED and 8.3% in PTC group. The mean PD-L1 staining of FED foci was 47.2% in FED group and 33.6% in PTC group. The mean tumor proportion score (TPS) was 10.4% and the mean combined positive score (CPS) was 15.5. At the moment, PTC is not a target of immunotherapy. However, understanding the complex issue of concurrent inflammation and autoimmunity can importantly influence the cancer treatment in future.
...
Publisher
WileyISSN Search the Publication Forum
0903-4641Keywords
Publication in research information system
https://converis.jyu.fi/converis/portal/detail/Publication/104574601
Metadata
Show full item recordCollections
Additional information about funding
The research was funded by VTR-grant from Pirkanmaa Hospital District, Tampere Tuberculosis Foundation and Pirkanmaa Cancer Foundation (all to I.K), the Charles University Research Fund (Progres Q28/LF1 (UNCE 204013)) (to D.K.), the Charles University Research Fund (Progres Q39) (to M.L.).License
Related items
Showing items with similar title or keywords.
-
Decorin Expression and Oncosuppression in Human Embryonic Carcinomas
Sainio, Annele; Pennanen, Mirka; Laine, Jukka; Lund, Riikka; Söderström, Mirva; Kuopio, Teijo; Järveläinen, Hannu (Fortune Journals, 2019)Human embryonic stem cells in culture can transform into malignant, cancer-like cells exhibiting lesser differentiation. After transplantation, these transformed cells can form highly malignant germ cell tumors. In humans, ... -
CD3+ and CD8+ T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
Karjula, Topias; Elomaa, Hanna; Niskakangas, Anne; Mustonen, Olli; Puro, Iiris; Kuopio, Teijo; Ahtiainen, Maarit; Mecklin, Jukka-Pekka; Seppälä, Toni, T.; Wirta, Erkki-Ville; Sihvo, Eero; Väyrynen, Juha, P.; Yannopoulos, Fredrik; Helminen, Olli (MDPI AG, 2023)Simple Summary The lung is the second most common site of metastases in colorectal cancer (CRC). The aim of our study was to evaluate the prognostic value of CD3+ and CD8+ T-cell density based immune cell score (ICS) ... -
Quantitative multiplexed analysis of indoleamine 2,3-dioxygenase (IDO) and arginase-1 (ARG1) expression and myeloid cell infiltration in colorectal cancer
Elomaa, Hanna; Härkönen, Jouni; Väyrynen, Sara A.; Ahtiainen, Maarit; Ogino, Shuji; Nowak, Jonathan A.; Lau, Mai Chan; Helminen, Olli; Wirta, Erkki-Ville; Seppälä, Toni T.; Böhm, Jan; Mecklin, Jukka-Pekka; Kuopio, Teijo; Väyrynen, Juha P. (Elsevier, 2024)Indoleamine 2,3-dioxygenase (IDO) and Arginase-1 (ARG1) are amino acid metabolizing enzymes frequently highly expressed in cancer. Their expression may deplete essential amino acids, lead to immunosuppression, and promote ... -
Primary sclerosing cholangitis dysplasia-carcinoma sequence : possibilities in early stage molecular pathology
Mustamäki, Taru (2020)Primaarinen sklerosoiva kolangiitti, eli PSC on krooninen tulehduksellinen sappiteiden sairaus, joka aiheuttaa sappiteihin arpeutumista ja ahtaumia. PSC potilaista 20 % saa pelättynä huonoennusteisena komplikaationa ... -
Critical Structural Defects Explain Filamin A Mutations Causing Mitral Valve Dysplasia
Haataja, Tatu J.K.; Capoulade, Romain; Lecointe, Simon; Hellman, Maarit; Merot, Jean; Permi, Perttu; Pentikäinen, Ulla (Elsevier (Cell Press); Biophysical Society, 2019)Mitral valve diseases affect approximately 3% of the population and are the most common reasons for valvular surgery because no drug-based treatments exist. Inheritable genetic mutations have now been established as the ...